CASE/0212/06/24 - Voluntary admission by Sanofi

Voluntary admission about an advertisement for Nexviadyme (avalglucosidasealfa) in a conference brochure

  • Case number
    CASE/0212/06/24
  • Complaint received
    18 June 2024
  • Completed
    18 March 2025
  • Appeal hearing
    No appeal
  • Applicable Code year
    2021
  • Breach Clause(s)
  • Sanctions applied
    Undertaking received
  • Additional sanctions

Case Summary

This case was in relation to an advertisement intended for a pull-up banner being sent in error for inclusion in a conference brochure.

The outcome under the 2021 Code was:

Breach of Clause 5.1

Failing to maintain high standards

Breach of Clause 12.1

Failing to include prescribing information

This summary is not intended to be read in isolation.
For full details, please see the full case report below.